Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease

References

• Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med 1997;336:924–32.
   PubMed Web of Science ®Google Scholar
• Liebermann-Meffert D, Allgower M, Schmid P, Blum AL. Muscular equivalent of the lower esophageal sphincter. Gastroenterology 1979;76:31–8.
   PubMed Web of Science ®Google Scholar
• Adler RH, Firme CN, Lanigan JM. A valve mechanism to prevent gastroesophageal reflux and esophagitis. Surgery 1958;44:63–76.
   PubMed Web of Science ®Google Scholar
• Hill LD, Kozarek RA. The gastroesophageal flap valve. J Clin Gastroenterol 1999;28:194–7.
   PubMed Web of Science ®Google Scholar
• Hill LD, Kozarek RA, Kraemer SJ, Aye RW, Mercer CD, Low DE, The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc 1996;44:541–7.
   PubMed Web of Science ®Google Scholar
• Kim GH, Kang DH, Song GA, Kim TO, Heo J, Cho M, Gastroesophageal flap valve is associated with gastroesophageal and gastropharyngeal reflux. J Gastroenterol 2006;41:654–61.
   PubMed Web of Science ®Google Scholar
• Kim GH, Song GA, Kim TO, Jo HJ, Kim do H, Heo J, Endoscopic grading of gastroesophageal flap valve and atrophic gastritis is helpful to predict gastroesophageal reflux. J Gastroenterol Hepatol 2008;23:208–14.
   PubMed Web of Science ®Google Scholar
• Frazzoni M, De Micheli E, Grisendi A, Savarino V. Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression. Aliment Pharmacol Ther 2002;16:881–6.
   PubMed Web of Science ®Google Scholar
• Lee TJ, Fennerty MB, Howden CW. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2004;20:1241–51.
   PubMed Web of Science ®Google Scholar
• Robinson M. Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders. Aliment Pharmacol Ther 2004;20(Suppl 6):30–7.
   PubMed Web of Science ®Google Scholar
• Cloud ML, Enas N, Humphries TJ, Bassion S. Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group. Dig Dis Sci 1998;43:993–1000.
   PubMed Web of Science ®Google Scholar
• Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004;2:656–64.
   PubMed Web of Science ®Google Scholar
• Shimazu T, Matsui T, Furukawa K, Oshige K, Mitsuyasu T, Kiyomizu A, A prospective study of the prevalence of gastroesophageal reflux disease and confounding factors. J Gastroenterol 2005;40:866–72.
   PubMed Web of Science ®Google Scholar
• Lee ES, Kim N, Lee SH, Park YS, Kim JW, Jeong SH, Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease. Aliment Pharmacol Ther 2009;30:154–64.
   PubMed Web of Science ®Google Scholar
• Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–80.
   PubMed Web of Science ®Google Scholar
• Nandurkar S, Talley NJ. Barrett's esophagus: the long and the short of it. Am J Gastroenterol 1999;94:30–40.
   PubMed Web of Science ®Google Scholar
• Vianna A, Hayes PC, Moscoso G, Driver M, Portmann B, Westaby D, Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology 1987;93:876–89.
   PubMed Web of Science ®Google Scholar
• Noda T. Angioarchitectural study of esophageal varices. With special reference to variceal rupture. Virchows Arch A Pathol Anat Histopathol 1984;404:381–92.
   PubMedGoogle Scholar
• Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;3:87–97.
   Google Scholar
• Kimura K, Satoh K, Ido K, Taniguchi Y, Takimoto T, Takemoto T. Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl 1996;214:17–20; discussion 21–3.
   PubMedGoogle Scholar
• Fass R, Fennerty MB, Ofman JJ, Gralnek IM, Johnson C, Camargo E, The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42–9.
   PubMed Web of Science ®Google Scholar
• WHO/IASO/IOTF. The Asian-Pacific perspective: redefining obesity and its treatment. Geneva, Switzerland, WHO Western Pacific Region, 2000.
   Google Scholar
• Contractor QQ, Akhtar SS, Contractor TQ. Endoscopic esophagitis and gastroesophageal flap valve. J Clin Gastroenterol 1999;28:233–7.
   PubMed Web of Science ®Google Scholar
• Xirouchakis E, Kamberoglou D, Kalos D, Zambeli E, Doulgeroglou V, Tzias V. The effect of gastroesophageal flap valve appearance on the management of patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci 2009;54:328–32.
   PubMed Web of Science ®Google Scholar
• Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998;10:119–24.
   PubMed Web of Science ®Google Scholar
• Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997;11:765–73.
   PubMed Web of Science ®Google Scholar
• Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001;96:1711–7.
   PubMed Web of Science ®Google Scholar
• Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000;61:6–13.
   PubMed Web of Science ®Google Scholar
• Ruszniewski P, Soufflet C, Barthelemy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study. Aliment Pharmacol Ther 2008;28:1134–9.
   PubMed Web of Science ®Google Scholar
• Cryer B, Spechler S. Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on acid reflux in patients with gastroesophageal reflux disease (GERD). Gastroenterology 2000;4(Suppl 2):A862.
   Google Scholar
• Jacobson BC. Body mass index and the efficacy of acid-mediating agents for GERD. Dig Dis Sci 2008;53:2313–7.
   PubMed Web of Science ®Google Scholar
• Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006;354:2340–8.
   PubMed Web of Science ®Google Scholar
• Choi CW, Kim GH, Song CS, Wang SG, Lee BJ, I H, Is obesity associated with gastropharyngeal reflux disease? World J Gastroenterol 2008;14:265–71.
   PubMed Web of Science ®Google Scholar
• Labenz J, Tillenburg B, Peitz U, Idstrom JP, Verdu EF, Stolte M, Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996;110:725–32.
   PubMed Web of Science ®Google Scholar
• Labenz J, Tillenburg B, Peitz U, Borsch G, Idstrom JP, Verdu E, Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol 1997;92:576–81.
   PubMed Web of Science ®Google Scholar
• Gillen D, Wirz AA, Neithercut WD, Ardill JE, McColl KE. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 1999;44:468–75.
   PubMed Web of Science ®Google Scholar
• Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999;117:11–6.
   PubMed Web of Science ®Google Scholar
• Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330–4.
   PubMed Web of Science ®Google Scholar
• Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001;49:335–40.
   PubMed Web of Science ®Google Scholar
• Fujiwara Y, Higuchi K, Shiba M, Watanabe T, Tominaga K, Oshitani N, Association between gastroesophageal flap valve, reflux esophagitis, Barrett's epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol 2003;38:533–9.
   PubMed Web of Science ®Google Scholar
• Hunt RH. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995;9(Suppl 1):3–7.
   PubMed Web of Science ®Google Scholar
• Satoh K, Kimura K, Taniguchi Y, Yoshida Y, Kihira K, Takimoto T, Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol 1996;91:963–9.
   PubMed Web of Science ®Google Scholar
• Ito S, Azuma T, Murakita H, Hirai M, Miyaji H, Ito Y, Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 1996;39:800–6.
   PubMed Web of Science ®Google Scholar
• Liu Y, Uemura N, Xiao SD, Tytgat GN, Kate FJ. Agreement between endoscopic and histological gastric atrophy scores. J Gastroenterol 2005;40:123–7.
   PubMed Web of Science ®Google Scholar